BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.5% | 8.3% | 8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.4% | 59.7% | 58.5% | 56.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.9% | -16.5% | -16.8% | -18.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27.7% | -47.9% | -29.7% | -40.6% |
| EPS Diluted | -0.14 | -0.24 | -0.13 | -0.17 |
| % Growth | 41.7% | -84.6% | 23.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |